Poseida Therapeutics Inc. Gains 37.88%
Wed, Aug 09, 2023 at 07:38 PM
Poseida Therapeutics Inc. (PSTX:NASDAQ) soared at $2.73, representing a gain of 37.9%. On Wed, Aug 09, 2023, PSTX:NASDAQ touched a New 2-Week High of $2.73. The stock got featured on our News Catalysts scanner on Tue, Aug 08, 2023 at 06:31 PM in the 'EARNINGS' category. From Wed, Jul 26, 2023, the stock recorded 50.00% Up Days and 45.45% Green Days
About Poseida Therapeutics Inc. (PSTX:NASDAQ)
Poseida Therapeutics Inc is a clinical-stage biopharmaceutical company focused on leveraging non-viral gene engineering technologies to create life-saving therapeutics for patients with a high unmet...
Top 10 Gainers:
- Tango Therapeutics Inc. (TNGX:NASDAQ), 103.92%
- Renovaro Biosciences Inc. (RENB:NASDAQ), 82.35%
- Decibel Therapeutics Inc. (DBTX:NASDAQ), 80.29%
- Benitec Biopharma Inc. (BNTC:NASDAQ), 65.8%
- Science 37 Holdings Inc. (SNCE:NASDAQ), 53.24%
- Kubient Inc. (KBNT:NASDAQ), 44.37%
- Scopus BioPharma Inc. (SCPS:NASDAQ), 42.5%
- Poseida Therapeutics Inc. (PSTX:NASDAQ), 37.88%
- Esports Technologies Inc. (EBET:NASDAQ), 37.5%
- Planet Green Holdings Corp. (PLAG:NYSEMKT), 34.89%